Technology
Negative
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Breaking news from global financial markets
2 hours ago
Read More
2 hours ago
4,289
Onto Innovation (ONTO): Reassessing Valuation After Analyst Upgrades and New Growth Guidance
Insider Trading
2 hours ago
4,464
2 hours ago
2,080
2 hours ago
3,504
2 hours ago
1,924
2 hours ago
2,009
2 hours ago
1,104
3 hours ago
4,485
3 hours ago
4,219
3 hours ago
4,836
3 hours ago
4,015
AvePoint (AVPT): Valuation Perspectives After Strong Earnings, Raised Guidance, and Strategic Microsoft Partnership
Insider Trading
3 hours ago
2,411
3 hours ago
3,020
What Catalysts Could Shift the Narrative for NatWest Amid Analyst Upgrades and New Challenges
Ratings
3 hours ago
3,486
3 hours ago
3,326
Coinbase Owns 'Institutional Trust' in Crypto—But 3 Public Rivals Are About To Test That Claim
Crypto
3 hours ago
1,212
Trending Now
1
NFL Betting Promos: BetUS' New Customer Bonus for NFL Betting
24,029
33 minutes ago
2
XRP Ledger Reveals Major Smart Contract Milestone: Details
30,924
39 minutes ago
3
Prediction: EV Stocks Will Be Your Best Investment in 2026. Here's Why.
47,269
1 hour ago
4
FAA Orders Grounding of MD-11 Planes After Kentucky Crash
15,068
1 hour ago
5
2 AI Stocks That Could Go Parabolic
40,418
1 hour ago